• Jan Abkowitz, MD

    University of Washington

  • Jodie Babitt, MD

    Harvard Medical School

  • Jonathan Barasch, MD, PhD

    Columbia

  • Matthew Barber, PhD

    University of Oregon

  • Anna Beaudin, PhD

    University of Utah

  • Lionel Blanc, PhD

    Feinstein Institutes for Medical Research

  • The goal of my lab is to utilize genomic and proteomic approaches in hematopoietic stem cells as well as mouse models to study molecular mechanisms regulating cell fate decisions. Our research specially focuses on studying post-transcriptional regulation by ubiquitin E3 ligases in stem cell self-renewal, maintenance, and differentiation. Our work has demonstrated a key role of UBR5 in hematopoietic stem cell development and maintenance Interestingly, over expression of Ubr5 during hematopoietic development leads to bone marrow failure, loss of hematopoietic stem and progenitor cells, and anemia by 6 weeks of age in homozygous UBR5 mutant mice suggesting a novel model to study bone marrow failure. We also study the FBOX family of ubiquitin E3 ligases, which contains ~69 E3 ligases. To date only 15 of the 69 FBOX proteins have a known role in normal hematopoiesis. We are currently studying a number of FBOX proteins to understand their role in hematopoietic stem cell maintenance, and differentiation. Our aim is to understand basic mechanisms underlying hematopoietic specification.

    Read more: Buckley, Shannon

    Shannon Buckley, PhD

    University of Utah

  • Robert Campbell, PhD

    University of Utah

  • Monique Cho, MD

    University of Utah

  • Robert Christensen, MD

    University of Utah

  • Jan Christian, PhD

    University of Utah

  • James Cox, PhD

    University of Utah

  • Harry Dailey, PhD

    University of Georgia

  • Robert Desnick, MD, PhD

    Mt. Sinai

  • Adrienne M. Dorrance, PhD

    University of Utah

  • Research Interests

    Our research focuses on understanding and re-purposing the biochemistry of “good” microbes for health and biotechnology applications. This work is powered by the spectacular diversity of microbes and gene products that have come to light in the post-genomic age. Microbial life has adapted to every imaginable environmental niche – from the human gut to the hot spring – by evolving an array of cofactors and protein-based catalysts.

    We specialize in metal/cofactor-driven biochemistry at the aerobic/anaerobic interface. This exciting space is critical both for the proper functioning of the human microbiome and for powering environmental reactions that capture carbon dioxide and convert small organic molecules into useful materials. A long term goal of this research is to re-engineer natural reactions for biotechnological and biomedical applications, whether in the flask or in modified microbial hosts.

    Read more: DuBois, Jennifer

    Jennifer DuBois, PhD

    Montana State University

  • Richard Eisenstein, PhD

    U Wisconsin-Madison

  • Nels Elde, PhD

    University of Utah

  • The primary focus of my lab is to understand the molecular mechanisms that govern myeloid blood cancers, with particular emphasis on myeloproliferative neoplasms (MPNs). The long-term vision for my research program is to elucidate molecular dependencies specific to MPN stem cells (MPN-SCs) that can be targeted for therapeutic intervention with the ultimate goal of eradicating MPN-SCs, sparing normal HSCs, and curing the disease. The focus of my research program during the first five years of my independent career was to identify differential molecular dependencies in type 1 versus type 2 calreticulin (CALR) mutated MPNs. As a postdoctoral fellow, I identified the shared gain-of-function mechanism by which both type 1 and type 2 mutant CALR proteins transform cells to drive disease. This work served as a foundation to subsequently understand how these two mutation types differ in their disease driving mechanisms. To this end, we identified the unfolded protein response (UPR) as differentially exploited by type 1 and type 2 CALR mutant cells, and that the UPR arm preferentially activated by each mutation type is dependent on specific losses-of-function (LOFs) engendered by type 1 versus type 2 CALR mutations. We found that type 1 CALR mutations cause loss of calcium (Ca2+) binding function, leading to depletion of ER Ca2+ and activation of and dependency on the IRE1/XBP1 pathway of the UPR, while type 2 CALR mutations cause loss of chaperone function leading to activation of and dependency on the ATF6 pathway of the UPR. These discoveries led us to investigate how these LOFs affect other cellular processes, and found that loss of Ca2+ binding by type 1 CALR mutations leads to metabolic reprogramming and a dependency on glycolytic metabolism via increased cytosolic and mitochondrial Ca2+, while loss of chaperone function leads to impaired MHC-I processing and dysregulation of natural killer cell-based immune surveillance of type 2 CALR mutant cells. We are currently seeking to understand how these observations affect MPN-SCs and other disease-driving cells in primary human cell and mouse models, and whether these pathways represent novel therapeutic targets that can eradicate MPN-SCs to cure the disease.

    Read more: Elf, Shannon

    Shannon Elf, PhD

    University of Utah

  • Tomas Ganz, MD, PhD

    UCLA

  • Feng Guo, PhD

    UCLA

  • Hans Haecker, MD, PhD

    University of Utah

  • Iqbal Hamza, PhD

    University of Maryland

  • Kyle Hewitt, PhD

    University of Nebraska College of Medicine

  • Kevin Hicks, PhD

    University of Utah School of Medicine

  • Adam Hughes, PhD

    University of Utah

  • Oleh Khalimonchuk, PhD

    University of Nebraska – Lincoln

  • Mei Koh, PhD

    University of Utah

  • Scot Leary, PhD

    U of Saskatchewan

  • Betty Leibold, PhD

    University of Utah

  • Natural and synthetic physiology of life’s resilience

    We are fascinated by the natural and synthetic physiology of life’s resilience. Many organisms in nature have evolved specialized traits to respond and adapt to severe environmental stresses, including hypothermia (cold) or hypoxia (low oxygen). For example, Arctic ground squirrels can tolerate extremely low levels of oxygen in the brain and heart during hibernation. Most nematodes, including those from Antarctica and the common model organism C. elegans, can enter “suspended animation” states upon anoxia; they can also be frozen alive and suspend life that can be revived later virtually any long after freezing, unlike many other multicellular organisms. We use cultured neural stem cells from hibernating Arctic ground squirrels and nematodes with extremophile-like phenotypes recapitulated in the laboratory as discovery tools to discover novel cellular and physiological resilience mechanisms. Genes identified from such systems via large-scale experimental screens or computational mining often encode proteins of unusual properties that define novel mechanisms underlying cytoprotection, cellular organelle dynamics, and organismal homeostasis in physiology and behaviors. Some were even acquired from extremophile microbes via horizontal gene transfers and functionally co-opted to confer stress resilience. We take advantage of findings from our research and aim to use synthetic physiology approaches to engineer biological systems that may foster new means of neuroprotection, organ transplantation, reversible cryo-preservation, and therapeutics to treat ischemic, neurological, and age-related disorders.


    Current lab members:

    Andrew Wong (URAP student)
    Bingying Wang (Lab manager)
    Dengke Ma (Principal Investigator)
    Fiona Oh (URAP student)
    Jason DeGeorge (URAP student)
    Jenny Zu (URAP student)
    Minseo Kim (URAP student)
    Taruna Pandey (Postdoc)
    Wei Jiang (Postdoc)
    Winfred Zhijian Ji (Postdoc)

    Read more: Ma, Dengke

    Dengke Ma, PhD

    University of California – San Francisco

  • Don McClain, MD, PhD

    Wake Forest

  • Amy Medlock, PhD

    University of Georgia

  • Elizabeta Nemeth, PhD

    UCLA

  • Ryan O’Connell, PhD

    University of Utah

  • Charles Parker, MD

    University of Utah

  • Randall Peterson, PhD

    University of Utah

  • Aaron Petrey, PhD

    University of Utah

  • Caroline Philpott, MD

    NIDDK

  • Josef Prchal, MD

    University of Utah

  • Amit Reddi, PhD

    Georgia Institute of Technology

  • Matthew Rondina, MD, MS

    University of Utah

  • Jared Rutter, PhD

    University of Utah

  • Paul Sigala, PhD

    University of Utah

  • Jihyun Song, PhD

    University of Utah

  • Dean Tantin, PhD

    University of Utah

  • Francesca Vinchi, PhD

    New York Blood Center

  • Diane Ward, PhD

    University of Utah

  • Yvette Yien, PhD

    University of Pittsburg